EUCTR2015-005286-24-BE进行中（未招募）1 期
Baclofen in managing acute alcohol withdrawal
未提供0 个研究点开始时间: 2016年1月5日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Be an inpatient at unit A220 (UZ Brussel) at time of study enrolment.
- •Be able to sign informed consent.
- •Be male/female aged 18-60
- •Primary diagnosis of alcohol use disorder.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 90
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Pregnancy and breastfeeding.
- •Benzodiazepine use of more than the equivalent of lorazepam 5 mg /day.
- •(to assess this we will adopt the table included in annex 1)
- •Psychosis, confusion and acute mania.
- •Parkinson’s disease.
- •Use of tricyclic antidrepressants.
- •Use of opioids.
- •Known baclofen or benzodiazepine sensitivity or allergy.
- •Unable to take oral meds.
- •EGFR < 60 (blood samples are routinely performed at intake).
- •Prior diagnosis of epilepsy.
- •Lactose intolerance.
研究者
相似试验
招募中
3 期
A trial to compare safety and efficacy of Baclofen and Diazepam in Alcohol Withdrawal Syndrome.CTRI/2011/08/001938Dr Anshul Jhanwar50
进行中（未招募）
不适用
Baclofen for the Treatment of Alcohol Dependence - BACLADAlcohol DependenceEUCTR2010-021861-62-DECharité - Universitätsmedizin Berlin
已完成
3 期
High-dose baclofen for the treatment of alcohol addiction * A double-blind, randomized, placebo-controlled studyverslavingaddictionNL-OMON41310Academisch Medisch Centrum130
进行中（未招募）
不适用
High-dose baclofen for the treatment of alcohol addictioAlcohol dependenceEUCTR2011-004142-17-NLAcademic Medical Centrum250
已完成
不适用
Treating Alcohol Withdrawal With Oral BaclofenAlcohol Withdrawal DeliriumNCT00597701Essentia Health79